HS
RMD icon

Horan Securities’s ResMed RMD Stock Holding History

Horan Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$2.19K – 523
2023
Q2 		$2.19K Hold
10
– – ﹤0.01% 563
2023
Q1 		$2.19K Hold
10
– – ﹤0.01% 558
2022
Q4 		$2.08K Hold
10
– – ﹤0.01% 557
2022
Q3 		$2K Hold
10
– – ﹤0.01% 500
2022
Q2 		$2K Hold
10
– – ﹤0.01% 567
2022
Q1 		$2K Hold
10
– – ﹤0.01% 455
2021
Q4 		$3K Buy
+10
New +$2.6K ﹤0.01% 433
2021
Q2 		$2K Hold
10
– – ﹤0.01% 413
2021
Q1 		$2K Buy
+10
New +$2K ﹤0.01% 374

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Horan Securities's RMD Position: Q3 2023 in Review

Horan Securities sold out of ResMed (RMD) in Q3 2023, closing a stake of 10 shares — an estimated $2.19K sold.

Horan Securities first reported a position in RMD in Q1 2021 and held it in 9 quarters. The position peaked at $3K in Q4 2021. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Horan Securities reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 10 ResMed shares in Q3 2023, an estimated $2.19K.
  • Horan Securities first reported a position in ResMed in Q1 2021 and held it in 9 quarters.
  • Horan Securities's ResMed position peaked at $3K in Q4 2021.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.